AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
THIAMAZOLE
9 registrations across 2 African markets— 8 active
Markets with THIAMAZOLE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| THYROZOL Comprimé pelliculé sécable / 10 mg | 🇹🇳Tunisia | Merck Santé s.a.s | expired | Aug 2015 |
| THYROZOL comprime / 20 mg | 🇸🇳Senegal | — | active | — |
| THYROZOL comprime / 5 mg | 🇸🇳Senegal | MERCK | active | — |
| THYROZOL comprime / 10 mg | 🇸🇳Senegal | MERCK | active | — |
| THIAMAZOLE-GH comprime / 5 mg | 🇸🇳Senegal | GENERIC HEALTHCARE PVT.LDT SHIVAJINAGAR | active | — |
| THYROZOL comprime / 5 mg | 🇸🇳Senegal | MERCK | active | — |
| THIAMAZOLE comprime pellicule / 10 mg | 🇸🇳Senegal | GENERIC HEALTHCARE PVT.LTD | active | — |
| THYROZOL comprime / 20 mg | 🇸🇳Senegal | — | active | — |
| THYROZOL comprime / 10 mg | 🇸🇳Senegal | MERCK | active | — |
THIAMAZOLE in Africa — Regulatory Overview
THIAMAZOLE is registered across 2 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Senegal, Tunisia. AfricaRegulatory refreshes this data daily from official government sources.
Of the 9 registrations, 8 (89%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.